Larimar Therapeutics Inc (LRMR)

Precedente Chiudi:

$7.86

Aprire:

$7.96

Volume 24 ore:

361.84K

Capitalizzazione di mercato:

$454.26M

Reddito:

-

Utile/perdita netta:

$-36.95M

Rapporto P/E:

-7.7391

EPS:

-0.92

Flusso di cassa netto:

$-33.46M

1 W Prestazione:

-8.31%

1M Prestazione:

+4.09%

6M Prestazione:

+190.61%

1 anno Prestazione:

+39.06%

Intervallo 1D:

$7.08

$7.96

Portata 52W:

$2.18

$13.68

Larimar Therapeutics Inc Stock (LRMR) Company Profile

Nome

Larimar Therapeutics Inc

Settore

Healthcare (1212)

Industria

Biotechnology (699)

Telefono

844 511 9056

Indirizzo

Three Bala Plaza East, Suite 506, Bala Cynwyd, PA

Dipendente

16

Cinguettio

Prossima data di guadagno

2024-05-29

Ultimi documenti SEC

LRMR's Discussions on Twitter

Larimar Therapeutics Inc Borsa (LRMR) Ultime notizie

Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development

GlobeNewswire Inc.

Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia

GlobeNewswire Inc.

Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference

GlobeNewswire Inc.

Over $37M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

Benzinga

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

GlobeNewswire Inc.

Cisco Issues Weak Outlook, Joins Fastly, Herbalife And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Benzinga

Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari

Larimar Therapeutics Inc (LRMR) Reddito netto 2024

Larimar Therapeutics Inc (LRMR) Flusso di cassa 2024

Larimar Therapeutics Inc (LRMR) Utile per azione 2024

Larimar Therapeutics Inc Azioni (LRMR) insider trading